ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0733

Cerebrovascular Accidents in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study

Saman Tanveer1, Pranathi Bandarupalli2, Vineeth Potluri3, Fatima Tanveer4 and Abdullah Saeed5, 1The University of Chicago, Chicago, IL, 2Mercy St Vincent Medical Center, Toledo, OH, 3Mercy Health St. Vincent Medical Center, Toledo, OH, 4CMH Lahore Medical College and Institute of Dentistry, Lahore, Punjab, Pakistan, 5John H. Stroger Jr. Hospital of Cook County, Chicago, IL

Meeting: ACR Convergence 2025

Keywords: giant cell arteritis, Stroke

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0731–0764) Vasculitis – Non-ANCA-Associated & Related Disorders Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: To assess the characteristics, interventions, and outcomes of cerebrovascular accidents (CVAs) in people with giant cell arteritis (GCA). Strokes are uncommon in this population, however, it is uncertain whether patients with GCA are at a higher risk of stroke compared to the general population.

Methods: A retrospective cohort study was performed by analyzing the National Inpatient Sample (NIS) 2017-2022 for all patients with GCA, GCA with Polymyalgia Rheumatica (PMR), and Cerebral Infarction as primary or secondary diagnoses via ICD-10 (International Classification of Diseases 10th Revision) codes. Frequencies, demographics, and trends were determined and compared between hospitalized patients with GCA or GCA with PMR and those without GCA or GCA with PMR. STATA version 17 was used for data analysis. A p-value of ≤0.05 was considered statistically significant.

Results: Hospitalized patients with stroke who had GCA or GCA with PMR were less likely to be male (32.7% vs. 50.5%, p < 0.001), less likely to have history of smoking (12.57% vs 19.73%, p < 0.001), more likely to have concomitant hypertension (89% vs 84.45%, p < 0.001 or concomitant peripheral vascular disease (15.26% vs 9.61%, p < 0.001), less likely to undergo intravenous thrombolysis (4.7% vs 8.5%, p < 0.001), and less likely to undergo mechanical thrombectomy (2.8% vs 4.9%, p < 0.001), have a higher mortality (5.16% vs 4.65%, p=0.045) when compared to hospitalized patients with stroke who do not have GCA or GCA with PMR.

Conclusion: Hospitalized patients with stroke who had GCA or GCA with PMR were more likely to be female, older in age, have concomitant hypertension and less likely to undergo mechanical thrombectomy or intravenous thrombolysis when compared to patients with stroke without GCA or GCA with PMR. The cohort with GCA or GCA with PMR also had higher mortality when compared to the cohort without GCA or GCA with PMR.

Supporting image 1Table 1: Characteristics of Hospitalized Stroke Patients with and without GCA or GCA with PMR

Supporting image 2Table 2: Multivariate Regression Analysis of Outcomes Among GCA or GCA with PMR Patients Admitted With Stroke


Disclosures: S. Tanveer: None; P. Bandarupalli: None; V. Potluri: None; F. Tanveer: None; A. Saeed: None.

To cite this abstract in AMA style:

Tanveer S, Bandarupalli P, Potluri V, Tanveer F, Saeed A. Cerebrovascular Accidents in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/cerebrovascular-accidents-in-patients-with-giant-cell-arteritis-a-population-based-retrospective-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cerebrovascular-accidents-in-patients-with-giant-cell-arteritis-a-population-based-retrospective-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology